HOPA Now is the official podcast of the Hematology/Oncology/Pharmacy Association, an organization dedicated to supporting pharmacy practitioners and promoting the advancement of Hematology/Oncology/Pharmacy to optimize the care of individuals impacted by cancer.

 

These educational podcasts are part of our BCOP Preparatory and Recertification Course, which is designed to prepare oncology pharmacists preparing to sit for the BCOP Certification Exam, as well as meet the BPS requirement to complete a BCOP Preparatory/Recertification Review Course.

 

In this episode of HOPA Now, HOPA Fellow Dr. Robert Mancini shares information regarding cancer screening and prevention, including health and lifestyle factors, top genetic and familial risk factors, and effective pharmacological interventions. He concludes with an update on the ACS goal to increase cancer screening and prevention methods by the year 2035.

 

In this episode you will learn:

Screening and prevention information

• What do we know about cancer prevention and risk factors?
• Understanding accurate guidelines for cancer prevention
• Additional recommendations include smoking cessation and use of sunscreen
• Pharmacological interventions — what really works?
• Average vs. high-risk cancer screening options and controversy
• Genetic and familial syndromes
• An update on the ACS 2035 challenge

 

Mentioned in This Episode:

HOPA

ACS 2035 Challenge

 

Quotes:

“Education is the key to moving cancer prevention forward.” — Robert Mancini

 

“Rates of liver, pancreas, and uterine cancers will all increase if nothing is done to improve detection.” — Robert Mancini

 

“If major risk factors decrease and screening rates among Americans increase, … there will be an additional 20.5% drop of overall cancer deaths by the year 2035.” — Robert Mancini